Against this backdrop, more companies are entering the field. On Wednesday, Lepu Medical announced during its earnings call that its non-invasive BCI-related products have already generated revenue, and animal trials of its interventional multi-channel BCI product have been completed, with the product having entered the next-phase clinical research stage, according to yicai.com.

　　Yicai.com reported that financing for BCI companies has boomed since 2025, citing an industry report.

　　In 2025 alone, about 25 financing events took place, with total funds raised standing at almost 1.45 billion yuan. In the first quarter of 2026, there were 17 financing events, which raised more than in all of 2025.

　　In March, Shanghai-based Stairmed announced a strategic funding round of 500 million yuan, led by Alibaba and followed by Tencent, marking the deep entry of internet giants into the BCI sector.